AT

Andrew Peter Thomas

AA Astrazeneca Ab: 22 patents #12 of 1,971Top 1%
ZL Zeneca Limited: 17 patents #8 of 867Top 1%
ZA Zeneca Pharma S. A.: 9 patents #1 of 20Top 5%
IC ICI: 5 patents #277 of 2,189Top 15%
AL Astrazeneca Uk Limited: 2 patents #48 of 159Top 35%
RA Roche Palo Alto: 1 patents #205 of 347Top 60%
GE Genzyme: 1 patents #498 of 891Top 60%
Overall (All Time): #58,647 of 4,157,543Top 2%
48
Patents All Time

Issued Patents All Time

Showing 25 most recent of 48 patents

Patent #TitleCo-InventorsDate
10457664 Quinazoline derivatives as VEGF inhibitors Elaine Sophie Elizabeth Stokes, Laurent Francois Andre Hennequin 2019-10-29
10301267 Compounds David Buttar, Kevin Michael Foote, Maria-Elena Theoclitou 2019-05-28
9688640 Methods of treating cancer with a pyrazole derivative David Buttar, Kevin Michael Foote, Maria-Elena Theoclitou 2017-06-27
9040548 Quinazoline derivatives as VEGF inhibitors Elaine Sophie Elizabeth Stokes, Laurent Francois Andre Hennequin 2015-05-26
8697696 Triazole compounds II Stephen Deems Gabriel 2014-04-15
8642608 Quinazoline derivatives as VEGF inhibitors Elaine Sophie Elizabeth Stokes, Laurent Francois Andre Hennequin 2014-02-04
8604022 N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof Kevin Michael Foote, Maria-Elena Theoclitou, David Buttar 2013-12-10
8129391 N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof Kevin Michael Foote, Maria-Elena Theoclitou, David Buttar 2012-03-06
RE42353 Quinazoline derivatives and pharmaceutical compositions containing them Craig Johnstone, Edward Clayton, Elaine Sophie Elizabeth Stokes, Jean-Jacques Marcel Lohmann, Laurent Francois Andre Hennequin 2011-05-10
7737149 N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof David Buttar, Kevin Michael Foote, Maria-Elena Theoclitou 2010-06-15
7579344 Pyrimidine derivatives possessing cell-cycle inhibitors activity David William Heaton 2009-08-25
7579349 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer Thorsten Nowak 2009-08-25
7521453 Pyrimidine derivatives as modulators of insulin-like growth factor-1 receptor (IGF-I) Bernard Christophe Barlaam, Andrew Pape 2009-04-21
7485638 Pyrimidine compounds Nicholas John Newcombe 2009-02-03
7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity Nicholas John Newcombe 2008-12-16
7446105 Pyrimidine compounds Nicholas John Newcombe 2008-11-04
7442697 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity Nicholas John Newcombe 2008-10-28
7427626 2-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitors 2008-09-23
7173038 Quinazoline derivatives as VEGF inhibitors Elaine Sophie Elizabeth Stokes, Laurent Francois Andre Hennequin 2007-02-06
7087602 Cinnoline derivatives and use as medicine Laurent Francois Andre Hennequin 2006-08-08
6969714 Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation Gloria Anne Breault, Nicholas John Newcombe 2005-11-29
6939872 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors Nicholas John Newcombe 2005-09-06
6908920 Pyrimidine derivatives Nicholas John Newcombe, David William Heaton 2005-06-21
6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases 2005-06-14
6897210 Quinazoline derivatives and pharmaceutical compositions containing them Craig Johnstone, Edward Clayton, Elaine Sophie Elizabeth Stokes, Jean-Jacques Marcel Lohmann, Laurent Francois Andre Hennequin 2005-05-24